undamentalytics Newsletter

Conmed vs Stevanato Group S.p.a.

Conmed and Stevanato Group S.p.a. are similar in size: $1.37bn and $1.34bn of revenue in their latest fiscal years. Stevanato Group S.p.a. grew faster (12.3% against 5.2%). Stevanato Group S.p.a. kept more of each dollar of sales as profit: a net margin of 11.8% against 3.4%. Stevanato Group S.p.a. carries less debt relative to equity (30.6% against 80.8%).

Latest fiscal yearConmedCNMD, 2025Stevanato Group S.p.a.STVN, 2025
Revenue $1.37bn $1.34bn
Revenue growth 5.2% 12.3%
Net income $47.1m $158m
Operating margin 7.5% 16.8%
Net margin 3.4% 11.8%
Return on equity 4.7% 9.9%
Free cash flow $151m $25.2m
Cash $40.8m $153m
Total debt $835m $534m
Debt to equity 80.8% 30.6%
Dividend per share $0.60 —
Dividend yield 1.7% 0.3%
Share buybacks — —
Employees 3,900 —
Market value $1.46bn $3.97bn
Price vs our value range Below our value range —
Moat score 63 (Moderate) —
Insider trades, 12 months 0 buys, 2 sales 0 buys, 8 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.